These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 15808575)

  • 1. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
    Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation.
    Fujishiro J; Kudou S; Iwai S; Takahashi M; Hakamata Y; Kinoshita M; Iwanami S; Izawa S; Yasue T; Hashizume K; Murakami T; Kobayashi E
    Transplantation; 2006 Sep; 82(6):804-12. PubMed ID: 17006328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
    Fujishiro J; Suzuki C; Kudou S; Yasue T; Hakamata Y; Takahashi M; Murakami T; Hashizume K; Kobayashi E
    J Heart Lung Transplant; 2006 Jul; 25(7):825-33. PubMed ID: 16818126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
    den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
    Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
    J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide attenuated the rejection of major histocompatibility complex fully-mismatched cardiac allografts in mice.
    Yan S; Zhang QY; Zhou B; Xue L; Chen H; Wang Y; Zheng SS
    Transplant Proc; 2009 Jun; 41(5):1855-8. PubMed ID: 19545743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study.
    Ulusal BG; Ulusal AE; Hung LM; Wei FC
    J Surg Res; 2006 Apr; 131(2):261-6. PubMed ID: 16457843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished cytotoxic gene expression in rat cardiac transplants with low-dose cyclosporine/methotrexate combination therapy.
    Pizarro TT; Malinowska K; Kovacs EJ; Clancy J; Robinson JA; Piccinini LA
    Transplantation; 1994 Jul; 58(2):223-32. PubMed ID: 8042241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of mycophenolic acid combined with KRP-203, a novel immunomodulator, in a rat heart transplantation model.
    Suzuki C; Takahashi M; Morimoto H; Izawa A; Ise H; Fujishiro J; Murakami T; Ishiyama J; Nakada A; Nakayama J; Shimada K; Ikeda U; Kobayashi E
    J Heart Lung Transplant; 2006 Mar; 25(3):302-9. PubMed ID: 16507424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
    Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
    Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitor cytokine interleukin-1 receptor antagonist synergistically augments cyclosporine immunosuppression in a rat cardiac allograft model.
    Shiraishi M; Csete M; Yasunaga C; McDiarmid SV; Vannice JL; Busuttil RW; Shaked A
    J Surg Res; 1995 May; 58(5):465-70. PubMed ID: 7745957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of antigen-dependent and antigen-independent factors on the development of graft vasculopathy in a fully allogeneic cardiac allograft model in the rat.
    Fiedel S; Bayer J; Schaub M; Heidt MC; Grebe M; Tillmanns H; Stadlbauer TH
    Transplant Proc; 2009; 41(6):2625-7. PubMed ID: 19715988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
    Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
    Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation.
    Xia J; Jiang X; Huang Y; Zhang K; Xiao S; Yang C
    Chin Med J (Engl); 2003 Mar; 116(3):432-5. PubMed ID: 12781053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection.
    Mark W; Schneeberger S; Seiler R; Stroka DM; Amberger A; Offner F; Candinas D; Margreiter R
    Transplantation; 2003 Apr; 75(7):940-5. PubMed ID: 12698077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.